Stay updated on Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:25:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.3 released, updating from v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag appeared, and the prior government funding/operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:43.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A site-wide funding notice about government funding delays has been added, and the page shows a new revision banner (v3.4.1) replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:29:52.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page shows a Show glossary option and minor text updates, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a new 'Revision: v3.4.0' banner. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:50.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and Revision: v3.3.3 has been removed from the Study Documents section. This is a minor metadata update that does not affect study content, results, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:11:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.